Examining the Association and Prevalence of Chronic Subdural Hematoma Along with its Contributing Factors in Kashan City from the Years 2015 to 2022

Document Type : Original Article(s)

Authors

1 Trauma Research Center, Department of Neurosurgery, Kashan University of Medical Sciences, Kashan, Iran

2 Trauma Research Center, Kashan University of Medical Sciences, Kashan, Iran

3 Trauma Research Center, Kashan University of Medical Sciences, Kashan, Iran.

4 Department of Neurosurgery, Kashan University of Medical Sciences, Kashan, Iran

10.48305/jims.v43.i831.1164

Abstract

Background: Subdural hematoma complications typically arise from the rupture of veins within the subdural space. The chronic type of subdural hematoma have a more favorable prognosis when managed appropriately. This study aimed to examine the prevalence of chronic subdural hematoma and its associated factors in Kashan city from 2015 to 2022.
Methods: This research conducted a retrospective study involving 172 patients diagnosed with subdural hematoma from 2015 to 2022. Sampling was conducted, and patient information was gathered from their hospital records using a checklist. Data analysis was performed utilizing descriptive tests (such as prevalence, percentage, mean, and standard deviation) as well as inferential tests (including Chi-square, Fishers exact test, T-test, and ANOVA).
Findings: 127 patients (73.8%) were male, with the majority being over 60 years old (72.1%). The average length of hospitalization was approximately 8 days, and most patients reported symptoms lasting less than a month (55.8%). There was no significant relationship between various factors and the type or outcome of subdural hematoma (P > 0.05). Trend in the occurrence of hematoma cases showed an increase from 2015 to 2019, a decrease in 2020 to 2021, and then a rise again in 2022.
Conclusion: This study highlights the importance of raising public awareness regarding the symptoms of subdural hematoma, particularly among individuals over 60 and those with pre-existing health conditions. Screening programs should be implemented to enable early detection of this condition and to manage associated underlying diseases.

Highlights

Esmaeil Fakharian: Google Scholar, PubMed

Soudabeh Yarmohammadi: Google Scholar, PubMed

Keywords

Main Subjects


  1. Tamura R, Sato M, Yoshida K, Toda M. History and current progress of chronic subdural hematoma. J Neurol Sci 2021; 429: 118066.
  2. Yang W, Huang J. Chronic subdural hematoma: epidemiology and natural history. Neurosurg Clin N Am 2017; 28(2): 205-10.
  3. Adhiyaman V, Chattopadhyay I, Irshad F, Curran D, Abraham S. Increasing incidence of chronic subdural haematoma in the elderly. QJM 2017; 110(6): 375-8.
  4. Rauhala M, Luoto TM, Huhtala H, Iverson GL, Niskakangas T, Öhman J, et al. The incidence of chronic subdural hematomas from 1990 to 2015 in a defined Finnish population. J Neurosurg 2019; 132(4): 1147-57.
  5. Toi H, Kinoshita K, Hirai S, Takai H, Hara K, Matsushita N, et al. Present epidemiology of chronic subdural hematoma in Japan: analysis of 63,358 cases recorded in a national administrative database. J Neurosurg 2017; 128(1): 222-8.
  6. Nouri A, Gondar R, Schaller K, Meling T. Chronic Subdural Hematoma (cSDH): A review of the current state of the art. Brain Spine 2021; 1: 100300.
  7. Safari H, Zeinali M, Alizadeh P, Mahmoudi D. Topical dexamethason effectiveness combined with surgical intervention in patients suffering from chronic subdural hematoma. Interdisciplinary Neurosurgery. 2024; 37: 101984.
  8. Morovatshoar R, Dezfouli SAT, Teshnizi SH, Sheybani-Arani M, Khajavi-Mayvan F, Asl AS, et al. Prevalence of subdural and epidural hematoma in head trauma patients: a cross-sectional study. Disease and Diagnosis. 2023; 13(1): 1-5.
  9. Holl DC, Volovici V, Dirven CM, Peul WC, van Kooten F, Jellema K, et al. Pathophysiology and nonsurgical treatment of chronic subdural hematoma: from past to present to future. World Neurosurg 2018; 116: 402-11. e2.
  10. Feghali J, Yang W, Huang J. Updates in chronic subdural hematoma: epidemiology, etiology, pathogenesis, treatment, and outcome. World Neurosurg 2020; 141: 339-45.
  11. Osada Y, Shibahara I, Nakagawa A, Sakata H, Niizuma K, Saito R, et al. Unilateral chronic subdural hematoma due to spontaneous intracranial hypotension: a report of four cases. British journal of neurosurgery. 2020;34(6):632-7.
  12. Jafari N, Gesner L, Koziol JM, Rotoli G, Hubschmann OR. The pathogenesis of chronic subdural hematomas: a study on the formation of chronic subdural hematomas and analysis of computed tomography findings. World Neurosurg 2017; 107: 376-81.
  13. Kim J, Moon J, Kim T, Ahn S, Hwang G, Bang J, et al. Risk factor analysis for the recurrence of chronic subdural hematoma: a review of 368 consecutive surgical cases. Korean J Neurotrauma 2015; 11(2): 63-9.
  14. Tanaka Y, Ohno K. Chronic subdural hematoma–an up-to-date concept. J Med Dent Sci 2013; 60(2): 55-61.
  15. Mehta V, Harward SC, Sankey EW, Nayar G, Codd PJ. Evidence based diagnosis and management of chronic subdural hematoma: a review of the literature. J Clin Neurosci 2018; 50: 7-15.
  16. Quiñones-Ossa GA, Maurya VP, Deivasigamani B, Sánchez-Zambrano DC, Garcia-Ballestas E, Janjua T, et al. Management of Chronic Subdural Hematoma a Challenge in Neurosurgical Practice. J Neurointensive Care 2023; 6(2): 69-78.
  17. Mahmoodkhani M, Naeimi A, Zohrehvand A, Sabouri M, Heidari M. Gastrointestinal bleeding following traumatic brain injury: A clinical study on predisposing factors and outcomes. Caspian J Intern Med 2024; 15(4): 673-81.
  18. Miljković A, Milisavljević F, Bogdanović I, Pajić S. Epidemiology and prognostic factors in patients with subdural hematoma. Facta Universitatis, Series: Medicine and Biology. 2021; 22(2): 49-55.
  19. Ou Y, Dong J, Wu L, Xu L, Wang L, Liu B, et al. A comparative study of chronic subdural hematoma in three age ranges: below 40 years, 41–79 years, and 80 years and older. Clinical Neurology and Neurosurgery 2019; 178: 63-9.
  20. Vismoradi‑Aineh H, Alipour A, Ramezankhani A, Shakeri J, Yarmohammadi S, Marashi T. Investigating the relationship between satisfaction of basic psychological needs, general health, and some background variables in the Iranian older adults: a cross-sectional study. BMC Psychiatry 2022; 22(1): 372.
  21. Asghari E, Shakeri M, Parvan K, Sarbakhsh P, Davoodi A. Emergency nurses' knowledge and adherence to tissue plasminogen activator guidelines for patients with stroke [in Persian]. Hayat 2024; 30(1): 48-61.
  22. You W, Zhu Y, Wang Y, Liu W, Wang H, Wen L, et al. Prevalence of and risk factors for recurrence of chronic subdural hematoma. Acta Neurochir (Wien) 2018; 160(5): 893-9.
  23. Park H-R, Lee K-S, Shim J-J, Yoon S-M, Bae H-G, Doh J-W. Multiple densities of the chronic subdural hematoma in CT scans. J Korean Neurosurg Soc 2013; 54(1): 38-41.
  24. Wang S, Ma Y, Zhao X, Yang C, Gu J, Weng W, et al. Risk factors of hospital mortality in chronic subdural hematoma: a retrospective analysis of 1117 patients, a single institute experience. J Clin Neurosci 2019; 67: 46-51.
  25. Tabuchi S, Kadowaki M. Chronic subdural hematoma in patients over 90 years old in a super-aged society. J Clin Med Res 2014; 6(5): 379-83.
  26. Abdullah H, Dakurah T, Akoto H, Abaidoo B, Dakubo J, Yawson A, et al. Predictors of recurrence of chronic subdural haematoma in a cohort study of patients presenting in a sub-Saharan African teaching hospital. BMC Neurol 2022; 22(1): 346.
  27. Kostić A, Kehayov I, Stojanović N, Nikolov V, Kitov B, Milošević P, et al. Spontaneous chronic subdural hematoma in elderly people–Arterial hypertension and other risk factors. J Chin Med Assoc 2018; 81(9): 781-6.

Oh J-s, Shim J-J, Yoon S-M, Lee K-S. Influence of gender on occurrence of chronic subdural hematoma; is it an effect of cranial asymmetry? Korean J Neurotrauma 2014; 10(2): 82-5